Our news

  • We'll be at the 2020 IASP Pain World Congress, presenting "Evidence Synthesis for Determining Efficacy and Harm: Identifying a Quality Signal in the Growing Noise", a session on making sense of the increasing weight of evidence. For more information and details on how to register please see here. 
    December 12 2019
  • Prophylactic anti-emetics for patients receiving intravenous opioids in the acute care settingWe are looking for additional author support to join the existing author team in order to develop the protocol/review. The candidate will have some experience of contributing to Cochrane reviews, and will be famiiar with RevMan. The candidate is expected...
    November 29 2019
  • A great opportunity to develop your professional skills and advance your career as a researcher. Become a citizen scientist as part of an IASP Presidential Task Force reviewing studies in which cannabinoids were tested for antinociceptive effects.Prior knowledge of systematic reviews is not required, all training will be provided.To learn more and...
    November 27 2019
  • Our ten most accessed reviews in 2018 are shown below.Congratulations to everyone involved. 1. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews, Louise J Geneen, R Andrew Moore, Clare Clarke, Denis Martin, Lesley A Colvin and Blair H Smith. See full review here. 2. Cannabis-based medicine...
    September 30 2019
  • Our top ten most cited reviews contributing to the 2018 Impact Factor (i.e. those published in 2016 and 2017, and cited in 2018) are shown below.Congratulations to everyone involved.1. Physical activity and exercise for chronic pain in adults: an overview of Cochrane reviews (DOI: 10.1002/14651858.CD011279.pub3), Louise J Geneen, R Andrew Moore,...
    September 30 2019
  • We are proud to announce that the 2018 Impact Factor for PaPaS is 8.316 (76 publications cited 632 times), this is an increase on the 2017 Impact Factor which was 7.286. This means that a review published by PaPaS in 2016 and 2017 was cited, on average, 8.316 times in 2018. Please note this is an unofficial metric calculated by Wiley, publisher of...
    September 24 2019
  • PaPaS is part of the Cochrane Musculoskeletal, Oral, Skin and Sensory (MOSS) Network. A short film has been made which introduces the team, talks about what has happened so far, and the ambition for what is to come. Watch it here.
    July 16 2019
  • On the 20th June 2019, we published an overview review in the PAIN Journal on the efficacy of pharmacological interventions for children with chronic pain and cancer-related pain (https://bit.ly/2MMm5UH). The overview summarises the evidence from 23 systematic reviews, including several PaPaS reviews from our NIHR Programme Grant (https://papas....
    June 27 2019
  • We are delighted to announce our successful bid for Cochrane's Network Innovation funding. Read more about the initiative launched earlier this year here. Find out more about our project "Optimal methods for the use of ‘pain’ as an outcome in systematic reviews of postoperative pain management" here.
    June 17 2019
  • Can you help? We're looking for existing priorities in acute pain, chronic pain, headache & migraine, and palliative care. Please get in touch if you know of any relevant projects, completed or ongoing. Thank you! Read about our 2019 prioritisation plans here.
    June 17 2019


Subscribe to Our news